Video as a Tool to Improve Insight in Schizophrenia
VideoInsight
Video Self-observation as a Therapeutic Tool for Improving the Insight of Patients With Schizophrenia Disorders
1 other identifier
interventional
60
1 country
2
Brief Summary
The deficit of awareness of pathology (or insight) is a common symptom in patients with schizophrenia and has a negative impact on the prognosis of the disease. Current treatments aren't effective enough on this symptom (Pijnenbord et al., 2013). Previous studies have shown a positive impact of videos of patients themselves on insight but they lacked power. This technique needs more investigation. The study aims to improve the patient's awareness of pathology with a video of themselves recorded in the acute phase of their illness. Patients will watch this video after clinical stabilization. This is a randomized controlled and single blinded trial. A population of 60 patients (30 in each group) will be included. The impact on the insight, symptomatology, treatment adherence and functional remission will be evaluated. The video of patient is useful for a personalized clinical follow-up. Its use for therapeutic purposes would be innovative and could be extended to other applications in psychiatry, especially as this tool is readily available.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Dec 2015
Typical duration for not_applicable schizophrenia
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 8, 2015
CompletedFirst Submitted
Initial submission to the registry
January 11, 2016
CompletedFirst Posted
Study publicly available on registry
January 26, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 4, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2018
CompletedSeptember 30, 2025
December 1, 2020
2.8 years
January 11, 2016
September 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Unawareness of Mental Disorder (SUMD)
Scale to assess Unawareness of Mental Disorder (SUMD)
48 hours
Secondary Outcomes (8)
Insight
48 hours
Cognitif Insight
48 hours
Positive Symptom
48 hours
Negative Symptom
48 hours
Depression
48 hours
- +3 more secondary outcomes
Study Arms (2)
Experimental group with video
EXPERIMENTAL30 patients will watch the video of them in acute decompensation phase
Control group without video
SHAM COMPARATOR30 patients will not watch the video of them in acute decompensation phase, they pass a standard interview with psychometric scales
Interventions
Patients will watch the video of them in acute decompensation phase then they will be asked about their emotions, their understanding and awareness of mental illness
Patients will not watch the video of them in acute decompensation phase.
Eligibility Criteria
You may qualify if:
- Patients with a diagnosis of schizophrenia or schizoaffective disorder according to the DSM 5
- Age between 18 and 65 years
- Patients initially hospitalized for acute decompensation of their schizophrenia or schizoaffective disorder according to the medical records and any medical certificates
- Patients who agreed to be filmed during a standardized interview at screening (in acute decompensation phase of the disease at the beginning of hospitalization)
- Clinical state compatible with the therapeutic experience and obtaining consent with a score on the scale of PANSS positive symptoms of less than 24
You may not qualify if:
- Mental impairment moderate to severe
- Central nervous system disease or severe head trauma
- Chronic alcohol dependence
- Patients hospitalized for a social problem or otherwise, without acute decompensation of their schizophrenia or schizoaffective disorder as assessed by the referring psychiatrist
- Patients deprived of liberty by judicial decision
- Pregnant and breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University Hospital of Montpellier
Montpellier, 34295, France
University Hospital of Nîmes
Nîmes, 30029, France
Related Publications (1)
Schandrin A, Picot MC, Marin G, Andre M, Gardes J, Leger A, O'Donoghue B, Raffard S, Abbar M, Capdevielle D. Video self-confrontation as a therapeutic tool in schizophrenia: A randomized parallel-arm single-blind trial. Schizophr Res. 2022 Feb;240:103-112. doi: 10.1016/j.schres.2021.12.016. Epub 2022 Jan 3.
PMID: 34991040DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Aurélie SCHANDRIN, MD
University hospital of Nîmes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2016
First Posted
January 26, 2016
Study Start
December 8, 2015
Primary Completion
October 4, 2018
Study Completion
December 30, 2018
Last Updated
September 30, 2025
Record last verified: 2020-12